These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2217144)
21. Analysis of the structure-function relationship of tumour necrosis factor. Human/mouse chimeric TNF proteins: general properties and epitope analysis. Tavernier J; Marmenout A; Bauden R; Hauquier G; Van Ostade X; Fiers W J Mol Biol; 1990 Jan; 211(2):493-501. PubMed ID: 1689779 [TBL] [Abstract][Full Text] [Related]
22. Determination of binding site of anti-tumour necrosis factor-alpha monoclonal antibody using hybrid and mutant proteins. Shingarova LN; Sagaidak LN; Berkova N; Korobko VG FEBS Lett; 1996 May; 386(1):72-4. PubMed ID: 8635607 [TBL] [Abstract][Full Text] [Related]
23. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity. Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139 [TBL] [Abstract][Full Text] [Related]
24. [Correlation of cytotoxic activity of mutant forms of tumor necrosis factor alpha with changes in the level of free sphingosine in murine liver]. Solov'ev AS; Korobko VG; Shingarova LN; Vasil'eva SV; Makhova EV; Alesenko AV Biokhimiia; 1995 Aug; 60(8):1283-91. PubMed ID: 7578580 [TBL] [Abstract][Full Text] [Related]
25. Development of human tumor necrosis factor-alpha muteins with improved therapeutic potential. Jang SH; Kim H; Cho KH; Shin HC BMB Rep; 2009 May; 42(5):260-4. PubMed ID: 19470238 [TBL] [Abstract][Full Text] [Related]
26. Structure-activity studies of human tumour necrosis factors. Van Ostade X; Tavernier J; Fiers W Protein Eng; 1994 Jan; 7(1):5-22. PubMed ID: 8140094 [TBL] [Abstract][Full Text] [Related]
27. High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicity. Cha SS; Kim JS; Cho HS; Shin NK; Jeong W; Shin HC; Kim YJ; Hahn JH; Oh BH J Biol Chem; 1998 Jan; 273(4):2153-60. PubMed ID: 9442056 [TBL] [Abstract][Full Text] [Related]
28. A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor. Yang J; Moyana T; Xiang J Mol Immunol; 1995 Aug; 32(12):873-81. PubMed ID: 7565814 [TBL] [Abstract][Full Text] [Related]
29. High expression of tumor necrosis factor alpha cDNA in E. coli using site-specific deletion mutagenesis. Zhang DZ; Wu SH; Zhang ZQ; Jin Q; Zhao XH; Zhao XX; Su CZ; Hou YD Chin J Biotechnol; 1990; 6(3):157-64. PubMed ID: 2104206 [TBL] [Abstract][Full Text] [Related]
30. Significance of the 56th tyrosine on cytotoxic activity of tumor necrosis factor. Zhang D; Chen S; Chen N; Zhi G; Su C Chin J Biotechnol; 1992; 8(1):23-8. PubMed ID: 1457718 [TBL] [Abstract][Full Text] [Related]
32. A novel recombinant fusion toxin targeting HER-2/NEU-over-expressing cells and containing human tumor necrosis factor. Rosenblum MG; Horn SA; Cheung LH Int J Cancer; 2000 Oct; 88(2):267-73. PubMed ID: 11004679 [TBL] [Abstract][Full Text] [Related]
33. Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis. Van Ostade X; Tavernier J; Prangé T; Fiers W EMBO J; 1991 Apr; 10(4):827-36. PubMed ID: 2009860 [TBL] [Abstract][Full Text] [Related]
34. Construction of novel tumor necrosis factor-alpha mutants with reduced toxicity and higher cytotoxicity on human tumor cells. Liu H; Lu F; Chen J; Ren H; Chen C Sci China C Life Sci; 2003 Feb; 46(1):1-9. PubMed ID: 20213356 [TBL] [Abstract][Full Text] [Related]
36. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors. Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036 [TBL] [Abstract][Full Text] [Related]
37. Production of recombinant porcine tumor necrosis factor alpha in a novel E. coli expression system. Su X; Prestwood AK; McGraw RA Biotechniques; 1992 Nov; 13(5):756-62. PubMed ID: 1418978 [TBL] [Abstract][Full Text] [Related]
38. [Preparation of a mutant human tumor necrosis factor with increased resistance to proteases]. Korepanova AV; Eroshkin AM; Ivanisenko VA; Lebedev LR; Mikriukov NN; Pustoshilova NM; Petrenko VA; Il'ichev AA Mol Biol (Mosk); 1994; 28(1):143-9. PubMed ID: 8145742 [TBL] [Abstract][Full Text] [Related]
39. A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo. Yan Z; Zhao N; Wang Z; Li B; Bao C; Shi J; Han W; Zhang Y Cytotherapy; 2006; 8(4):415-23. PubMed ID: 16923618 [TBL] [Abstract][Full Text] [Related]
40. High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris. Sreekrishna K; Nelles L; Potenz R; Cruze J; Mazzaferro P; Fish W; Fuke M; Holden K; Phelps D; Wood P Biochemistry; 1989 May; 28(9):4117-25. PubMed ID: 2752013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]